MedPage Today (8/19, Grant) reports, “Nearly half of emergency medicine (EM) residents in the U.S (45.1%) reported being exposed to some form of mistreatment,” ranging “from discrimination based on race or gender to verbal and physical abuse,” according to findings from “a large survey study” published in JAMA Network Open. Researchers “also found a significant association between the frequency of mistreatment and reports of suicidal thoughts among EM trainees.”

Related Links:

— MedPage Today (requires login and subscription)

Healio (8/19, Gramigna) reports, “Co-occurrence of multiple abuse subtypes across childhood and adulthood was linked to higher psycho-social risk and suicide attempt history among military service members hospitalized due to suicide risk,” investigators concluded in a “latent class analysis” that sought “to elucidate how these abuse subtypes co-occur during childhood and adulthood among a high-risk sample of 115 military service members and adult beneficiaries who underwent psychiatric hospitalization after a suicide-related crisis.” The findings were published online ahead of print in the October issue of the Journal of Psychiatric Research.
“ Three latent classes were identified: Multiple and Persistent Abuse (Class One: 29.6%), Childhood Physical and Persistent Emotional Abuse (Class Two: 27.0%), and Minimal Abuse (Class Three: 43.5%). Females were more likely than males to report a history of Multiple and Persistent Abuse. After controlling for gender, the Multiple and Persistent Abuse Class had higher scores of depressive symptoms and hazardous drinking, poorer sleep quality, and increased social stress than the Minimal Abuse Class. Moreover, the Multiple and Persistent Abuse Class was associated with increased likelihood of lifetime” suicide attempts.

Related Links:

— “Abuse subtypes affect suicide risk among military psychiatric inpatients “Joe Gramigna, Healio, August 19, 2021

Healio (8/18, Gramigna) reports, “Patients hospitalized with serious mental illness had a cardiometabolic profile that conferred increased risk for diabetes and hypertension-related mortality,” researchers concluded in a study that “used a form of propensity score matching called entropy balancing to compare cardiometabolic health of a sample of the general population from the National Health and Nutrition Examination Survey…datasets with that of inpatients hospitalized in an urban psychiatric hospital in Texas.” The study team “analyzed data via independent linear regression models, with outcome variables including blood pressure, blood glucose, triglyceride to high-density lipoprotein…ratio, total cholesterol and BMI.” The findings of the “observational study” were published online ahead of print in the October issue of the journal Psychiatry Research.

Related Links:

— “Inpatients with severe mental illness at increased risk for diabetes, hypertension “Joe Gramigna, Healio, August 18, 2021

Healio (8/17, Gramigna) reports, “Austedo [deutetrabenazine] treatment appeared to improve involuntary movements and quality of life [QoL] among older adults with tardive dyskinesia,” researchers concluded in “a post hoc analysis of a long-term open-label extension study” that enrolled “a total of 337 participants.” The study revealed that “a total of 67% of younger and 76% of older participants, as well as 64% of younger and 63% of older participants, achieved treatment success,” and “both groups generally well tolerated deutetrabenazine.” The findings were published online Aug. 15 ahead of print in the American Journal of Geriatric Psychiatry.

Related Links:

— “Austedo improves quality of life in older adults with tardive dyskinesia “Joe Gramigna, Healio, August 17, 2021

MedPage Today (8/17, George) reports research indicates that patients with Parkinson’s disease “using pimavanserin (Nuplazid), a novel antipsychotic used to help manage Parkinson’s hallucinations and delusions, had an increased risk of 30-day hospitalization and higher mortality for up to a year.” The study compared “2,186 people who were prescribed pimavanserin and 18,212 who were not.” The findings were published online in the journal Neurology.

Related Links:

— MedPage Today (requires login and subscription)